Fiducial markers and their impact on ablation outcome for patients treated with MR-guided transurethral ablation (TULSA): a retrospective technical analysis

CONCLUSION: Marker composition, orientation and location inside the prostate can all potentially impact treatment outcome. Proper patient selection through detailed MRI screening is critical to ensure successful radiorecurrent PCa treatment outcomes with TULSA.PMID:34927517 | DOI:10.1080/02656736.2021.2008519

Source: International Journal of Hyperthermia - December 20, 2021 Category: Internal Medicine Authors: Cameron Wright Pietari M äkelä Mikael Anttinen Teija Sainio Peter J Bostr öm Roberto Blanco Sequeiros Source Type: research